Skip to main content

BioSystem, ProZyme Team on Glycan Sample Prep

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Madison, Wis.-based BioSystem Development and Hayward, Calif.-based ProZyme today announced that they are collaborating on a new sample preparation workflow for glycan sample preparation that combines their respective technologies.

The firm said that the first product will combine ProZyme's enzymatic N-deglycosylation, labeling, and cleanup chemistry with BioSystem Development's AssayMap high-throughput micro-chromatography platform. They added that the resulting platform provides rapid, quantitative N-glycan sample preparation fully enables for any scale of automation.

According to the partners, conventional glycan analysis methods are laborious and expensive and take up to three days or more to perform. They said that their GlykoScreen Rapid Glycosylation Sample Preparation System can process hundreds of samples in three hours or less.

"We believe that the products of this partnership will have a profound impact on advancing the field of glycobiology and look forward to leading this initiative," ProZyme President Jo Wegstein said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.